264 related articles for article (PubMed ID: 15466851)
1. Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care.
Sylvestre DL; Loftis JM; Hauser P; Genser S; Cesari H; Borek N; Kresina TF; Seeff L; Francis H
J Urban Health; 2004 Dec; 81(4):719-34. PubMed ID: 15466851
[TBL] [Abstract][Full Text] [Related]
2. Treating hepatitis C virus infection in active substance users.
Sylvestre DL
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S321-4. PubMed ID: 15768341
[TBL] [Abstract][Full Text] [Related]
3. Approaching treatment for hepatitis C virus infection in substance users.
Sylvestre DL
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S79-82. PubMed ID: 16265620
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders.
Rosenberg SD; Drake RE; Brunette MF; Wolford GL; Marsh BJ
AIDS; 2005 Oct; 19 Suppl 3():S26-33. PubMed ID: 16251824
[TBL] [Abstract][Full Text] [Related]
5. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
6. Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse.
Ho SB; Bräu N; Cheung R; Liu L; Sanchez C; Sklar M; Phelps TE; Marcus SG; Wasil MM; Tisi A; Huynh L; Robinson SK; Gifford AL; Asch SM; Groessl EJ
Clin Gastroenterol Hepatol; 2015 Nov; 13(11):2005-14.e1-3. PubMed ID: 25724704
[TBL] [Abstract][Full Text] [Related]
7. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care.
Fireman M; Indest DW; Blackwell A; Whitehead AJ; Hauser P
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S286-91. PubMed ID: 15768336
[TBL] [Abstract][Full Text] [Related]
8. Management of mental health problems prior to and during treatment of hepatitis C virus infection in patients with drug addiction.
Schaefer M; Sarkar R; Diez-Quevedo C
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S111-7. PubMed ID: 23884058
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric barriers to readiness for treatment for hepatitis C Virus (HCV) infection among injection drug users: clinical experience of an addiction psychiatrist in the HIV-HCV coinfection clinic of a public health hospital.
Scheft H; Fontenette DC
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S292-6. PubMed ID: 15768337
[TBL] [Abstract][Full Text] [Related]
10. Understanding associations between serious mental illness and hepatitis C virus among veterans: a national multivariate analysis.
Himelhoch S; McCarthy JF; Ganoczy D; Medoff D; Kilbourne A; Goldberg R; Dixon L; Blow FC
Psychosomatics; 2009; 50(1):30-7. PubMed ID: 19213970
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C treatment eligibility and outcomes among patients with psychiatric illness.
Rifai MA; Moles JK; Short DD
Psychiatr Serv; 2006 Apr; 57(4):570-2. PubMed ID: 16603757
[TBL] [Abstract][Full Text] [Related]
12. Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders.
Chainuvati S; Khalid SK; Kancir S; Shea M; Edwards J; Sernyak M; Wongcharatrawee S; Garcia-Tsao G
J Viral Hepat; 2006 Apr; 13(4):235-41. PubMed ID: 16611189
[TBL] [Abstract][Full Text] [Related]
13. The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone.
Sylvestre DL; Litwin AH; Clements BJ; Gourevitch MN
J Subst Abuse Treat; 2005 Oct; 29(3):159-65. PubMed ID: 16183464
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection, substance use and mental illness among homeless youth: a review.
Nyamathi AM; Christiani A; Windokun F; Jones T; Strehlow A; Shoptaw S
AIDS; 2005 Oct; 19 Suppl 3():S34-40. PubMed ID: 16251826
[TBL] [Abstract][Full Text] [Related]
15. Integrating care for patients with infectious, psychiatric, and substance use disorders: concepts and approaches.
Willenbring ML
AIDS; 2005 Oct; 19 Suppl 3():S227-37. PubMed ID: 16251823
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management.
Loftis JM; Matthews AM; Hauser P
Drugs; 2006; 66(2):155-74. PubMed ID: 16451091
[TBL] [Abstract][Full Text] [Related]
17. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Buxton JA; Wong J; Tyndall MW; Janjua NZ;
Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):200-210. PubMed ID: 28404135
[TBL] [Abstract][Full Text] [Related]
18. Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV.
Weiss JJ; Gorman JM
Curr HIV/AIDS Rep; 2006 Nov; 3(4):176-81. PubMed ID: 17032577
[TBL] [Abstract][Full Text] [Related]
19. Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection.
Grebely J; Genoway K; Khara M; Duncan F; Viljoen M; Elliott D; Raffa JD; DeVlaming S; Conway B
Int J Drug Policy; 2007 Oct; 18(5):437-43. PubMed ID: 17854734
[TBL] [Abstract][Full Text] [Related]
20. Adherence to hepatitis C treatment in recovering heroin users maintained on methadone.
Sylvestre DL; Clements BJ
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):741-7. PubMed ID: 17700258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
